Esophageal Cancer

 

Trastuzumab plus Trimodal Treatment for Esophageal Cancer
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Investigator: Veena Shankaran, MD;   Conditions: Esophageal Cancer;    Status: Recruiting;   Study ID: NCT01196390

PET Scan Imaging for Patients with Esophageal Cancer
Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer

Investigator: Veena Shankaran, MD;   Conditions: Esophageal Cancer;    Status: Recruiting;   Study ID: NCT01333033